BMJ

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, ...
BMJ

Power Doppler ultrasonography and synovitis: correlating ultrasound imaging with histopathological findings and evaluating the performance of ultrasound equipments

1 Department of Internal Medicine, Mikkeli Central Hospital, Mikkeli, Finland 2 Department of Nuclear Medicine, Mikkeli Central Hospital, Mikkeli, Finland 3 Department of Pathology, Mikkeli Central ...
BMJ

Patient and provider barriers to effective management of gout in general practice: a qualitative study

Correspondence to Michael Doherty, University of Nottingham, Department of Academic Rheumatology, Academic Rheumatology Clinical Sciences Building City Hospital, Nottingham NG5 1PB, UK; ...
BMJ

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

GI Motility Program, Divisions of Gastroenterology and Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, CSMC Burns & Allen Research Institute, Los Angeles, California 90048, School ...
BMJ

Paracetamol and cyclooxygenase inhibition: is there a cause for concern?

1 Institute of Toxicology and Pharmacology, University of Rostock, Rostock, Germany 2 Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University ...
BMJ

Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial

1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...
BMJ

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

Objectives To examine the safety and efficacy of rontalizumab, a humanised IgG1 anti-interferon α (anti-IFN-α) monoclonal antibody, in patients with moderate-to-severe systemic lupus erythematosus ...
BMJ

Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials

Correspondence to Dr Michael M Ward, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, NIAMS/NIH, Building 10 CRC, Room ...
BMJ

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular ...

3 Institut National de la Santé et de la Recherche Medicale (INSERM CJF 96-02, IFR30), Purpan School of Medicine, University of Toulouse III, Toulouse, France 4 Department of Electrical Energy, ...
BMJ

Gout: why is this curable disease so seldom cured?

3 Department of Rheumatology, University of Edinburgh, Centre for Molecular Medicine, Western General Hospital, Edinburgh, Scotland, UK 4 Department of Medicine, Rheumatology Section, Alicante ...
BMJ

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

1 Renal Institute of Birmingham, School of Infection, Immunity and Inflammation, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK Objective To contrast the effect of ...
BMJ

Table of contents

The multiple rheumatological faces of PsA (or PsA is more than just poly-arthritis? - Consequences for management in daily practice) ...